Pages that link to "Q37193900"

The following pages link to The DcpS inhibitor RG3039 improves motor function in SMA mice. (Q37193900):

Displaying 33 items.

• Molecular Mechanisms of Neurodegeneration in Spinal Muscular Atrophy (Q26752798) (← links)
• Spinal muscular atrophy: development and implementation of potential treatments (Q26861377) (← links)
• Collaboration for rare disease drug discovery research (Q28650560) (← links)
• Loss of the scavenger mRNA decapping enzyme DCPS causes syndromic intellectual disability with neuromuscular defects (Q30649520) (← links)
• Protective effects of butyrate-based compounds on a mouse model for spinal muscular atrophy. (Q30743508) (← links)
• The effect of diet on the protective action of D156844 observed in spinal muscular atrophy mice. (Q33645966) (← links)
• Quality control of assembly-defective U1 snRNAs by decapping and 5'-to-3' exonucleolytic digestion. (Q34060813) (← links)
• Assays for the identification and prioritization of drug candidates for spinal muscular atrophy (Q34082155) (← links)
• Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cells (Q34142599) (← links)
• Spinal Muscular Atrophy Therapeutics: Where do we Stand? (Q34460251) (← links)
• A cell system for phenotypic screening of modifiers of SMN2 gene expression and function (Q34964785) (← links)
• Spinal muscular atrophy: from tissue specificity to therapeutic strategies (Q35029616) (← links)
• Advances in therapeutic development for spinal muscular atrophy (Q35167319) (← links)
• A library approach to rapidly discover photoaffinity probes of the mRNA decapping scavenger enzyme DcpS. (Q35626397) (← links)
• Disease mechanisms and therapeutic approaches in spinal muscular atrophy (Q35707832) (← links)
• DcpS is a transcript-specific modulator of RNA in mammalian cells (Q35773274) (← links)
• The effect of the DcpS inhibitor D156844 on the protective action of follistatin in mice with spinal muscular atrophy (Q35967715) (← links)
• A fluorescent HTS assay for phosphohydrolases based on nucleoside 5'-fluorophosphates: its application in screening for inhibitors of mRNA decapping scavenger and PDE-I. (Q35975257) (← links)
• Small Molecules in Development for the Treatment of Spinal Muscular Atrophy (Q36095048) (← links)
• Spinal muscular atrophy: an update on therapeutic progress (Q37302832) (← links)
• Antisense Oligonucleotides: Treatment Strategies and Cellular Internalization (Q37733136) (← links)
• Investigational therapies for the treatment of spinal muscular atrophy. (Q38441280) (← links)
• Developing therapies for spinal muscular atrophy (Q38546908) (← links)
• Discovery of a Small Molecule Probe That Post-Translationally Stabilizes the Survival Motor Neuron Protein for the Treatment of Spinal Muscular Atrophy. (Q38704353) (← links)
• Antisense Oligonucleotides: Translation from Mouse Models to Human Neurodegenerative Diseases (Q39391538) (← links)
• The human decapping scavenger enzyme DcpS modulates microRNA turnover (Q40302008) (← links)
• The effects of C5-substituted 2,4-diaminoquinazolines on selected transcript expression in spinal muscular atrophy cells (Q41000953) (← links)
• In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels. (Q42273778) (← links)
• Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS. (Q52686206) (← links)
• Cellular thermal shift and clickable chemical probe assays for the determination of drug-target engagement in live cells (Q58293026) (← links)
• Drug treatment for spinal muscular atrophy types II and III (Q89477851) (← links)
• Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy (Q91706732) (← links)
• Current and emerging treatment options for spinal muscular atrophy (Q97570201) (← links)